Introduction
Endothelial cells (ECs) form a semipermeable dynamic barrier that regulates the exchange of fluids and solutes between the vascular space and underlying tissues, and controls protein flux between the blood and subendothelial compartments , . Disruption of this [1 2 ] semi-selective barrier is a hallmark of several pathological conditions including inflammation, atherosclerosis and tumor angiogenesis. The barrier function of endothelial monolayers results from an equilibrium between adhesive strengths which connect ECs to each other via a complex set of junctional proteins and to the extracellular matrix (ECM) proteins via integrins, and contractile forces. Generation of contractile forces within endothelial cells can open intercellular gaps, and thus alter the barrier properties of the monolayer. Indeed, earlier reports have clearly established direct relationships between increased permeability and endothelial contraction leading to cell retraction [2 for review . Endothelial contraction is associated with an extensive rearrangement of actin microfilaments from a circumferential ring to ] stress fibres composed of bundles of polymerized actin and myosin filaments . It is now well-recognized that vascular permeability is [3 ] directly controlled by cytoskeleton rearrangements involving the formation of stress fibres.
On the other hand, increasing evidence suggests that lipid raft and caveolae membrane domains play an important role in the regulation of membrane-cytoskeleton interactions . Several cytoskeleton modulators such as phosphatidylinositol 4,5-bisphosphate [4 ] (PI4,5P2) or Rho GTPases, and cytoskeletal proteins such as actin and vimentin are associated with rafts . In epithelial cells, the [5 ] structural protein of tight junctions occludin, and the peripheral membrane protein ZO-1 that links tight junctions to actin cytoskeleton, have been found in the detergent-insoluble fractions constituting raft microdomains whereas other transmembrane proteins such as E-cadherin and beta-1 integrin were not enriched in these structures. In addition, part of occludin pool co-immunoprecipitated with caveolin-1 . Interestingly, phospholipase D (PLD) which is also involved in the regulation of cytoskeleton dynamics has been histamine has been shown to dose-dependently increase the PLD activity of human aortic endothelial cells and bradykinin proved to [12 ] be an effective PLD activator in bovine pulmonary aortic endothelial cells . Reactive oxygen species (ROS) generated in the [13 ] vasculature by activated neutrophils or vascular cells have also been implicated in increased endothelium permeability leading to barrier dysfunction. Interestingly, ROS have also been shown to stimulate PLD activity in several cell types including endothelial cells , . [14 15 ] A role for PLD and its product PA has been postulated in the regulation of actin cytoskeleton. The first observations that exogenous PA or lysophosphatidic acid (LPA)-induced PLD activation induced actin polymerisation were made by Exton s group in HC9 fibroblasts ' [ , . The fact that LPA-induced PA generation and stress fibre formation were both inhibited by 1-butanol, and not by 2-butanol, 16 17 ] suggested that PLD can control cytoskeletal reorganization. Similar results were obtained later by Cross et al. using porcine aortic [18 ] endothelial cells and by Porcelli et al. in human airway epithelial cells. Partial inactivation of PLD1 by stable expression of a [19 ] dominant negative mutant for rPLD1 markedly reduced LPA effects on both PLD activation and stress fibre formation . At variance [20 ] with the above results Su et al.
reported that PLD1 depletion of HeLa cells by shRNA or tetracycline-induced overexpression of [21 ] PLD1 in CHO cells did not alter the number of spontaneously formed stress fibres. However, the authors did not examine the possible role of PLD2.
To test the hypothesis that one or the other PLD isoform is an important regulator of endothelial permeability we examined the influence of changes in PLD expression or changes in intracellular PA levels on endothelial permeability and actin cytoskeleton organization, using a HUV-EC cell line. Our results show that enhancement of intracellular PA increases endothelial permeability and that PLD2 is more specifically involved in the regulation of basal endothelial permeability presumably due to its preferential localization into lipid rafts. Mechanistically, our observations suggest that PLD2 dependent increased endothelial permeability is linked to both PA-dependent cytoskeleton rearrangement and activation of the Raf-MEK-ERK1/2 signaling pathway which negatively regulates the expression level of occludin.
Materials and methods

Materials
Triton X-100 was from Pierce. Silica Gel G60 TLC plates were from VWR International (Fontenay sous-Bois, France). H -palmitic
acid was from Perkin Elmer Life Sciences. H 5 -AMP (specific activity 722 GBq/mmol), MP Hyperfilm, ECL were from GE Healthcare were kindly provided by Dr S. Bourgoin (Laval University, Canada). foetal calf serum, 2.5g/l sodium bicarbonate, 100 U/ml penicillin, 100 g/ml streptomycin and 1ml/100ml culture medium of endothelial μ cell growth factor, in 5 CO at 37 C in a humidified incubator. Treatments were carried out on 100 confluent cells. For adenoviral
Cell culture
amplification, HEK 293 cells were maintained in DMEM containing 5 (vol/vol) foetal calf serum, 100 U/ml penicillin, and 100 g/ml
The HRP flux which reflects the paracellular permeability was measured according to the procedure of Hirase et al. with slight [23 ] modifications. Briefly, HUV-EC were seeded onto 0.4 m polycarbonate Transwell filters (BD Falcon) coated with 5 g/ml fibronectin. -ATGGGGTGGAGACTTGGAAATC annealing to portion of the CMV promoter, which is brought in by homologous recombination.
Positive clones were further analyzed by restriction analysis. Positive recombinants were amplified in XL-1 blue, digested with PacI E.coli and finally transfected by the calcium phosphate method in HEK293 cells. Cytopathic effect due to virus production was observed 8 10 sequence similarity with any known mammalian gene was used as a negative control. Transfection of siRNA was performed using Xtreme
Gene reagent (Roche) with 50 nM siRNA in antibiotic-free medium. The cells were kept for 12 h in this medium and then shifted to complete culture medium for 48 h before treatment.
Reverse transcriptase and real time PCR
Total RNA was isolated from HUV-EC using Trizol Reagent (Invitrogen) according to the manufacturer s protocol. After 
Isolation and characterization of lipids rafts from HUV-EC
Lipids rafts were isolated according to the procedure of Diaz et al. based on the insolubility of these structures in cold non-ionic [27 ] detergent, with slight modifications. Briefly, 20 25 10 HUV-EC-C were homogenized in 1 ml of ice-cold lysis buffer (25 mM Tris, pH -× 6 7.5, 150 mM NaCl, 5 mM EDTA) supplemented with a mixture of protease inhibitors (protease inhibitor mixture Sigma). After centrifugation at 800 g at 4 C for 10 min, the post-nuclear supernatant was incubated with Triton X-100 at a final concentration of 1 for°% 1 h at 4 C. The lysate was then adjusted to 1.3 M sucrose by the addition of an equal volume of 2.6 M sucrose and placed at the bottom of°a n ultracentrifuge tube, and a step sucrose gradient (0.2 0.9 M with 0.1 M steps, 1 ml each) was placed on top. It was centrifuged at were determined by the method of Shaffner and Weissmann using BSA as a standard. Gradient protein recovery relative Proteins [28 ] to total proteins in the post nuclear supernatant varied from 60 to 91 . was quantified on dot blots according to Diaz et al.
. Briefly, 20 l of each gradient fraction were dotted Ganglioside M1 (GM1) [27 ] μ onto Immobilon using a Hybri-Dot Manifold apparatus (Bethesda). Membranes were rinsed with distilled water and blocked with 5%
bovine serum albumin in TBS-T for 2 h. After three 10-min washes with TBS-T, membranes were incubated with horseradish peroxidase-conjugated cholera toxin in TBS-T containing 1 bovine serum albumin for 90 min and then rinsed 7 times with TBS-T and % developed with the ECL reagent. The luminograms were quantified using cooled digital CCD camera system (ImageMaster VDS-CL, GE Healthcare, France) and Image Quant software. Results are expressed relative to the sum of the intensity of spots present in the different gradient fractions, taken as 100.
was determined enzymatically using a commercial assay kit (Sigma) according to the manufacturer s recommendations. Cholesterol 
Western blotting experiments
PLD
Cells were homogenized in 20 mM Tris/HCl pH 7.6 buffer containing 100 mM NaCl, 1 Triton, and protease inhibitors cocktail. Cell % lysates were mixed with Laemmli buffer supplemented with 2 M urea, boiled for precisely 1 min, and separated on 8 SDS % polyacrylamide gel including 4 M urea. The blots were probed with PLD1-and PLD2-specific polyclonal antibodies kindly provided by Dr S. Bourgoin (Laval University, Canada), diluted 1:2000. Immunoblots were revealed with the ECL detection system and x-ray film autoradiography. After stripping, the membranes were reprobed with an anti--tubulin monoclonal antibody for normalization. Bands were α then quantified using cooled digital CCD camera system and Image Quant software. Protein concentrations were routinely determined by the Bradford method using BSA as a standard.
[30 ]
Gradient fractions
30 l of gradient fractions were mixed with Laemmli buffer, boiled for 5 min, separated on SDS PAGE and electrotransferred on μ Immobilon P membrane. For immunodetection the following primary antibodies were used: caveolin-1 (dilution 1/750), occludin and E-cadherin (1 g/ml). The anti-mouse secondary antibody was diluted 1/10000; the anti-rabbit secondary antibody was diluted 1/5000. 
Immunoflurescence staining of occludin
Untreated or infected cells grown on 12-well plastic plates were preextracted with 0.1 Triton X-100 in 100 mM KCl, 3 mM MgCl2, in PBS containing 1 BSA. Primary anti-occludin antibody was diluted (1/25) in the same solution and incubated with the cells overnight.
%
After washing, cells were incubated with Alexa-fluor 546 coupled secondary mouse antibody for 1h. Labelled cells were examined by fluorescence microscopy.
Statistical analysis
Data expressed as means SEM were analyzed by one-way ANOVA and means were compared by a protected test. < 0.05 was ± t-P considered significant.
Results
PLD agonists increase endothelial permeability
We first evaluated the effects of physiological mediators of endothelial function on PLD activity and endothelial permeability of HUV-EC monolayers. In agreement with previous reports , both LPA and sphingosine 1-phosphate (S1P) increased the PLD [18 31 ] activity of HUV-EC monolayers, with maximal activation being obtained after 5 min of treatment. Although S1P effect was twice that of LPA at early time points, it declined very quickly. After 30 min of treatment S1P-stimulated PLD activity returned to basal level whereas LPA effect was maintained throughout this period and declined thereafter ( ). LPA also induced a time-dependent increase in Fig. 1A endothelial permeability for horseradish peroxidase (HRP) as compared with HRP passage through untreated cell monolayers (taken as 1 at each time point). The LPA-induced increase in permeability lasted for several hours, a maximal 1.7-fold increase being observed at 4 h ( ). After 24 h the permeability of LPA-treated monolayers did not differ significantly from that of untreated control monolayers. Fig. 1B S1P treatment of HUV-EC also increased HRP passage across monolayers. As observed for PLD activity, S1P effect was maximal earlier than LPA effect (1 h vs 4 h) and started to decline thereafter ( ). Fig. 1C 
Increased level of intracellular PA increases endothelial permeability
To explore further the potential role of PLD in the control of endothelial permeability, we examined the effects of several agents known to increase endogenous PA . The addition of a bacterial PLD from to HUV-EC monolayers [14 ] Streptomyces chromofuscus maximally increased HRP flux after 1 to 2 h of treatment, suggesting that a certain lag-time is necessary to achieve increase of PA level (
). In contrast, propranolol a well-known inhibitor of PA hydrolase which has been shown to induce endogenous PA accumulation Fig. 2A [ , markedly and rapidly increased endothelial permeability, maximal effect being already obtained after 30 min of treatment ( 32 33 ] Fig . 2B ). Finally, addition of the cell permeant di-C8-PA induced a gradual increase in permeability which peaked after 2 h and declined thereafter ( ). Similar effects were obtained with PA originating from egg yolk (not shown). 
PLD2 but not PLD1 overexpression increases basal endothelial permeability
Results of the above experiments indicate that enhancing endogenous PA level either through PLD activation or inhibition of PA degradation markedly increased endothelial permeability. To investigate further which PLD isoform is more specifically involved in the control of endothelial paracellular permeability, HUV-EC were infected with adenovirus constructs containing the cDNA of hPLD1b, or hPLD2, or GFP for control. Western blots in show that the expression level of both PLD1 and PLD2 was markedly increased in 
Downregulation of PLD1 and PLD2 differently affects basal and stimulated endothelial permeability
Given the lack of isoform specific PLD inhibitors, we examined the effect of PLD1 and PLD2 knockdown by means of specific siRNA on endothelial permeability. As shown in , both PLD1 and PLD2 siRNA reduced the level of the corresponding protein by Fig 4A around 70 without affecting the other isoform. Interestingly, only PLD2 silencing was able to reduce basal HRP flux across HUV-EC % monolayers confirming the prevalent role of PLD2 over PLD1 as a regulator of basal endothelial permeability ( ). PLD2 silencing Fig. 4B also suppressed LPA-induced short-term (30 min) increase in permeability, whereas PLD1 silencing did not ( ). In contrast, both ) to 8, which contained less than 4 of total proteins ( ). These low-density fractions were also enriched in cholesterol (about 30 of ± % N = contained part of the junctional protein occludin which has also been found in the detergent insoluble fractions of T84 epithelial cells . [6 ] In contrast, E-cadherin and claudin-1 were not preferentially associated with the raft fractions (not shown). Interestingly, a substantial part of PLD2 protein (42.6 1.8 , 3) was present in the low-density fractions of the gradient, whereas only 16. LPA-induced increase in endothelial permeability ( ). Altogether, these results indicate that raft integrity is necessary for Fig. 7C maintaining actin dynamics, and suggest that PLD2 effects on stress fibre formation and endothelial permeability that we observed in the present study might be related to the preferential location of the enzyme in raft domains.
PLD2 but not PLD1 overexpression downregulates occludin expression
Occludin plays a critical role in regulating the barrier function of endothelial monolayers. Indeed, the loss of occludin at endothelial junctions induced by VEGF treatment has been associated with an increased permeability of endothelial monolayers through a signaling pathway involving mitogen-activated protein (MAP) kinases . Given the results of the present study showing that PLD2 [34 ] overexpression increased HRP flux through HUV-EC monolayers ( ), we then compared the level of occudin expression in cells by a significant decrease of occludin mRNA levels ( ). Concomitantly with changes in occludin expression an increased level of Fig. 8D , phosphorylated ERK ( ) was also observed, whereas the level of phosphorylated p38 MAP kinase was not altered (  Figs. 8E and F  Figs. 8G ). In contrast, PLD1 overexpression did not induce significant changes in occludin expression level or ERK phosphorylation. These and H results show that PLD2 overexpression downregulates occludin and stimulates the MEK/ERK pathway, thus suggesting a possible link between both events, as it has been demonstrated in epithelial cells . Indeed, transient transfection of Pa-4 epithelial cells with a [35 ] constitutively active form of MEK1 drastically reduced occludin mRNA level, such downregulation being blocked by the MEK inhibitor PD98059 . [35 ] Activation of ERK1/2 by Raf-1 is required for PA-mediated increase of endothelial permeability PLD2 and endothelial permeability Biochim Biophys Acta . Author manuscript Page / 7 19 The MAP kinase pathway is known to mediate an elevation of endothelial permeability . To examine whether the MAP kinase [36 ] cascade was involved in PA induced hyperpermeability, HUV-EC were pretreated with the MEK inhibitors PD98059 and U-0126 before stimulation of cells with LPA. These compounds have been shown to prevent the activation of ERK1/2 and the subsequent phosphorylation of ERK1/2 substrates both in acellular systems and in intact cells , ) . As shown in , pretreatment of [37 inhibitor, GW-5074 . GW-5074 significantly attenuated LPA and PA-induced hyperpermeability ( ). Moreover, [40 ] Figs. 9B and C GW-5074 suppressed hyperpermeability induced by PLD2 overexpression without altering the permeability of PLD1-or GFP-overexpressing cells ( ). Western blotting experiments show that ERK1/2 was activated by PA and LPA ( ). Fig. 9D Figs. 9E-H Pretreatment of HUV-EC for 30 min with 100 nM GW-5074 reduced LPA and PA-induced ERK-1/2 phosphorylation ( ).
Figs. 9E-H
Altogether, these data show that Raf and ERK1/2 are downstream effectors of PA and are necessary for PA induced-hyperpermeability.
Discussion
The barrier function of vascular endothelium is a highly regulated process involving intricate signaling cascades . Any dysfunction [2 ] of this barrier may lead to pathological situations including inflammation and atherosclerosis. PLD and PLD-generated PA have been implicated in the increased permeability induced by ROS and pro-oxidant compounds, especially in bovine pulmonary arteries . [14 ] However the signaling pathways downstream of PLD leading to endothelium permeability changes have not been clearly defined. In the present study we used a variety of approaches to increase the intracellular PA and to establish potential links between elevation of PA level, cytoskeleton rearrangements, tight junction disturbance and increased endothelial permeability. We first used two agonists of lysophospholipid receptors, LPA and S1P , both of them having been shown to stimulate PLD activity in some types of cells. Indeed, pulmonary endothelial cells . Both LPA and S1P have been shown to either increase or decrease monolayer permeability depending on [46 ] the endothelial cell type considered. There are four LPA receptors and five S1P receptors identified in mammals to date . They are [41 ] coupled to a variety of downstream signaling cascades through different classes of G proteins including Gi, Gq, G . Whereas coupling 12/13 through G activates exclusively the RhoA pathway leading to stress fibre formation and increased permeability due to cell retraction 12/13 and intercellular gap formation, coupling through Gi activates both Rac and RhoA. Unlike RhoA, Rac activation induces cortical actin formation, assembly of adherens junctions and improves endothelial barrier function , . Thus, the final outcome of LPA and S1P [47 48 ] action on vascular permeability may be determined by the balance between RhoA and Rac activation depending on the type of endothelial cell considered. In the HUV-EC line used in the present study both LPA and S1P stimulated PLD activity, induced transient stress fibre formation and increased endothelial permeability, thus suggesting the prevalence of RhoA-dependent signaling pathways. Besides LPA and S1P, we used different treatments to increase PA intracellular level, namely exogenous dioctanoyl PA, propranolol and bacterial scPLD. Dioctanoyl PA, a cell permeant compound, has been shown to exert effects similar to those obtained with PLD-generated PA in various cell models . Propranolol, a well-known inhibitor of PA phosphohydrolase has been shown to increase PA levels in many [49 ] types of intact cells including smooth muscle cells or L6 myoblasts . Finally, PLD from has been [50 ] [ 33 ] Streptomyces chromofuscus widely used to induce PA synthesis in membranes of living cells to mimic the effects of endogenous mammalian PLD. In addition, this bacterial enzyme also possesses lysoPLD activity and is able to catalyze the synthesis of LPA from LPC , both activities leading to [51 ] increased PA level either directly or through LPA-induced endogenous PLD activation. The three agents used to enhance intracellular PA level increased HRP flux through endothelial monolayers and induced the formation of stress fibre bundles. The effect of PLD activation on cytoskeleton reorganization has been proposed to be due to the ability of PA to bind and activate the PI4P 5-kinase leading to an increased level of PI4,5P2 . PI4,5P2 is known to interact with several actin regulating proteins such as profilin, gelsolin or cofilin thus [52 ] promoting the formation of actin bundles . [53 ] It is well-recognized that actin polymerization is a Rho-dependent process . One of the best characterized targets of RhoA is the [54 ] p160 Rho kinase which phosphorylates the myosin light chains (MLC) directly and also inhibits MLC dephosphorylation. The resulting increase of MLC phosphorylation level contributes to actin stress fibre formation and increased actomyosin contractility . RhoA is [54 ] also a well-known PLD activator . Thus, it is conceivable that the RhoA-stimulated PA synthesis also contributes to stress fibre [8 ] accumulation. However, RhoA selectively activates the PLD1 isoform whereas PLD2 is not sensitive to RhoA regulation . In our cell [8 ] model, overexpressing PLD2 increased basal permeability ( ), possibly due to the formation of stable stress fibres ( ), and also through decreased expression of occludin and disturbance of intercellular junctions resulting from occludin loss ( ). PLD2 thus Fig. 8C seems to regulate basal endothelial permeability, as confirmed by the effect of PLD2 depletion which reduced basal permeability (Fig. 4B ). On the contrary, based on overexpression experiment ( ), PLD1 does not seem to regulate basal endothelial permeability. This Fig. 3B might be linked with the fact that overexpression of PLD1 induces by itself only a weak formation of stable stress fibres ( ), and Fig. 5B does not influence occludin expression and pericellular location ( ). This is in agreement with the inability of PLD1 depletion to Fig. 8C reduce basal permeability ( ). Fig. 4B It must be noticed that PLD1 activity under basal conditions, due to its much lower specific activity and lower level of expression [55 ] in HUV-EC cells (2-fold as evaluated by real time qPCR experiments, results not shown) as compared with PLD2, represents only a minor part of total PLD activity, and might thus play a negligible role. Instead, in LPA-stimulation conditions, PLD1 is likely to be activated [19 ] in particular via RhoA, and the contribution of PLD1 activity may become important. We indeed observed that PLD2-si RNA had a strong inhibitory effect on basal PLD activity, whereas PLD1-siRNA had no effect. Furthermore, PLD2-siRNA and PLD1-siRNA similarly inhibited LPA-stimulated PLD activity (not shown). Accordingly, PLD1 depletion, as well as PLD2 depletion, decreased the permeability measured after long term (2h) LPA treatment, suggesting that both PLD isoforms are necessary for LPA to increase permeability (Fig. 4D   ) .
Surprisingly, only PLD2 depletion strongly prevented rapid LPA-induced stress fibre formation while PLD1 depletion had no effect ( ), suggesting that stress fibres play little role in the increase in permeability induced by LPA. However, since the Figs. 5D and E observation of stress fibres was performed after a short treatment by LPA (15 min), whereas the suppression of permeability increase by PLD1-and PLD2-siRNAs was observed after 2 h of LPA treatment (when LPA-induced stress fibres have subsided), it is possible that only the short-term increase in permeability induced by LPA (0.5 1 h, ) was caused by transient stress fibre formation and cell - Fig. 1B retraction, and is thus dependent on the sole PLD2. In support to this, when permeability was measured after a short treatment by LPA (30 min), only PLD2 depletion significantly affected permeability, PLD1 depletion having no significant effect ( ). Instead, the delayed Fig. 4C increase in permeability induced by LPA ( 2 h), could be independent of transient stress fibres and necessitate both PLD1 and PLD2. In ≥ this regard, it has been claimed by several authors that PLD1 could be regulating PLD2, possibly through the production of PI4,5P2 , [56 57 . PLD2 might thus be the key player in endothelial permeability regulation, with PLD1 playing an accessory role. The observation that ] PLD1 and PLD2 isoforms differently affect basal cell functions has been made in other cell models. For example, Padron et al.
have [58 ] shown that only PLD2 silencing reduced the recycling of transferrin receptors in HeLa cells, whereas siRNA against PLD1 had no effect.
The difference of effect between PLD1 and PLD2 on endothelial permeability might also be related to their different subcellular localization. Our fractionation experiments showed that the proportion of PLD2 protein present in the low-density fractions of the gradient enriched in specific markers of raft structures and caveolin was about 2.7-fold higher than that of PLD1 ( ). Interestingly, PLD2 has Fig. 6 been described as the only PLD isoform present in lipid microdomains of primary cultured HUVEC . Results of the present study [10 ] showed that the integrity of raft structures/caveolae is a prerequisite for LPA effect on endothelial permeability. Indeed, pretreatment of HUV-EC with the cholesterol-sequestering agent filipin abrogated both actin stress fibre formation and increased HRP flux induced by LPA activation ( ). In bovine aortic endothelial cells, the formation of stress fibres induced by thrombin was only dependent on raft Fig. 7 integrity because it was suppressed by filipin but not by caveolae disorganization through caveolin depletion . Because cholesterol [59 ] sequestration alters both membrane rafts and caveolae, we cannot associate LPA effect, and thus PLD activation, to one or the other structure.
Besides cytoskeleton reorganization and cell contraction, interendothelial junctions, and among them tight junctions, represent another major device regulating endothelial permeability . It has been shown that the quality of the endothelial barrier is directly correlated to [2 ] the level of occludin expression . Furthermore the loss of occludin at endothelial and epithelial junctions appears to result from a [34 ] Raf-1-dependent activation of MAP kinase signal transduction cascade , . In the present study, we observed that PLD2 [60 61 ] overexpression induced a significant decrease of occludin expression at cell periphery. Downregulation of both occludin protein and mRNA was accompanied by a significant ERK1/2 activation evaluated by the level of phosphorylated ERK1/2 proteins. Unlike ERK1/2, p38 MAP kinase phosphorylation level was not modified by PLD2 overexpression. Because Raf-1 kinase is a well-known target of PA [39 , we further investigated whether Raf-1 kinase/MAP kinase were involved in the signaling pathway leading from PLD activation to ] increased permeability. We showed that the Raf kinase inhibitor GW-5074 was able to drastically reduce hyperpermeability induced by PLD2 overexpression. GW-5074 also inhibited the PA-and LPA-induced increase in endothelial permeability and ERK1/2 phosphorylation level, suggesting that hyperpermeability resulting from PA accumulation involved the sequential activation of Raf-1 and ERK1/2. It has been recently demonstrated that activation of the Raf/MEK/ERK1/2 pathway induces the upregulation of the transcriptional repressor Slug, which in turn inhibits occludin expression through interaction with the occludin promoter . On the other [60 ] hand, it is also known that MAP kinase activation can rapidly induce hyperpermeability through occludin displacement from tight-junctions . Thus, we propose that activation of the Raf/MEK/ERK1/2 pathway by increased PA intracellular level has both fast Effects of PLD overexpression on HUV-EC permeability. Panel A, HUV-EC in 35 mm culture dishes were infected with adenovirus coding for GFP (adeno-GFP), hPLD1 (adeno-PLD1) or hPLD2 (adeno-PLD2) using a viral particles to cell number ratio of 100, or not infected (NI). After 12 h, the viruses were washed out and cells were further incubated in fresh culture medium for 60 h. Whole cell lysates were then prepared, and 10 g of proteins were subjected to Western blotting as described in Materials and Methods using anti-PLD1 or anti-PLD2 
Fig. 6
Characterization of the low-density sucrose gradient fractions prepared from control HUV-EC. Triton X-100 lysates prepared from control HUV-EC were fractionated by floatation in a discontinuous sucrose density gradient, and the fraction were analyzed for (panel A) protein concentration and 5 -nucleotidase activity, (panel B) cholesterol and (panel C) GM1 content. Sucrose gradient is shown in panels B and C. to Western blot analysis using the corresponding primary antibodies.
Fig. 7
Effects of filipin on LPA-induced stress fibre formation and endothelial permeability. Panel A, HUV-EC monolayers were pretreated with 2 μ g/ml filipin for 30 min or left untreated. Medium was then removed by aspiration and cells were stimulated or not by 10 M LPA. After 15 
